Migraine linked to increased stroke risk in women

Be careful out there, you doctor should be warning you of Triptan risks;

Can This Patient Take A Triptan?: Review Of The Cardiovascular Safety Of The Triptans And Recommendations For Patient Selection And Evaluation

http://www.alphagalileo.org/ViewItem.aspx?ItemId=169391&CultureCode=en
Women who have migraines may have an increased risk of stroke, according to a preliminary study presented at the American Heart Association’s Scientific Sessions 2016.
Researchers studied 917 women who were being evaluated for heart disease and found those that had a history of migraines (224 or nearly 25 percent) were at higher risk of a future cardiovascular event – notably stroke.
They also found:

• Compared to those who did not report a history of migraines, women with a history of the headaches had an 83 percent higher risk of a cardiovascular event, including stroke or heart attack, during an average six-year follow-up.
• Women with history of migraine were 2.33 times more likely to suffer a stroke during the study than women who didn’t report migraines.

Additional Resources:

• Any available downloadable B-roll, animation and images related to the news tips are on the right column of the release link at
• My Life Check - Life's Simple 7
• Rise Above Heart Failure
• EmPOWERED to Serve
• For more news from the AHA’s Scientific Sessions 2016 follow us on Twitter @HeartNews  #AHA16.

###

http://newsroom.heart.org/news/tuesday-scientific-sessions-news-tips?preview=77a0166f7e17abb69564eec0e96973af

• Full bibliographic informationMigraine Headaches and Cardiovascular Outcomes in Women With Symptoms and Signs of Ischemic Heart Disease: Results of an Extended follow-up From the Women’s Ischemia Syndrome Evaluation
  
  Cecil A Rambarat, Islam Y Elgendy, Univ of Florida, Gainesville, FL; B. Delia Johnson, Univ of Pittsburgh, Pittsburgh, PA; Carl J Pepine, Univ of Florida, Gainesville, FL; C Noel Bairey Merz, Cedars-Sinai, Los Angeles, CA; Vera A Bittner, Univ of Alabama, Birmingham, AL; Steven E Reis, Univ of Pittsburgh, Pittsburgh, PA; Diane V Thompson, Cardiovascular Inst, Pittsburgh, PA; Bina Ahmed, Dartmouth-Hitchcock Medical Ctr, Lebanon, NH
  
  American Heart Association's Scientific Sessions 2016
  November 12-16 in New Orleans, Louisiana

Can This Patient Take A Triptan?: Review Of The Cardiovascular Safety Of The Triptans And Recommendations For Patient Selection And Evaluation

Be careful out there. It's a world full of stroke risks. I'm sure your doctor is well aware of this, it is only 12 years old.
https://ispub.com/IJN/3/1/9243

E Loder, D Biondi

Citation

E Loder, D Biondi. Can This Patient Take A Triptan?: Review Of The Cardiovascular Safety Of The Triptans And Recommendations For Patient Selection And Evaluation. The Internet Journal of Neurology. 2003 Volume 3 Number 1.

Abstract

Background: Treatment guidelines issued in 2001 by the United States Headache Consortium emphasize the use of 5-HT1B/1D agonists (triptans) as preferred agents for abortive treatment of moderate to severe migraine. Despite this, triptans are used by only a minority of patients whose attacks are severe enough to require prescription medication, primarily because of persistent concern about their cardiovascular safety.

Discussion: Serious triptan-related cardiac events have occurred, primarily in patients with known cardiac risk factors, but the efficacy and safety of triptans favor their use for the acute treatment of migraine in patients at low risk for cardiovascular disease. The use of simple, validated risk stratification systems such as the Framingham Risk Score, is one method of evaluating cardiovascular risk status in a clinical setting.

Summary: Triptans are safe for the majority of patients with migraine, but clinical assessment of the underlying probability of cardiovascular disease is important prior to triptan prescription.